
    
      Participants will be randomly assigned, in a 1:1 ratio, to receive Dexmedetomidine or control
      (0.9 %Sodium Chloride Solution,0.9%NaCl). The randomization sequence will be
      computer-generated, and randomization will be performed in blocks and will be stratified
      according to participating center. Dexmedetomidine and 0.9 % NaCl solution will be transfused
      when the operation began, ending 24 hours after the surgery. Troponin I level(but are not
      limited to these data) at pre-operation and 3h, 6h,12h, 24h, 48h after PCI will be recorded.
      At the same time, other dates will be recorded.The participation of each patient is scheduled
      for 12 months.
    
  